Annual Total Assets
$59.90 M
-$13.37 M-18.25%
30 April 2024
Summary:
PharmaCyte Biotech annual total assets is currently $59.90 million, with the most recent change of -$13.37 million (-18.25%) on 30 April 2024. During the last 3 years, it has risen by +$52.50 million (+709.05%). PMCB annual total assets is now -33.90% below its all-time high of $90.62 million, reached on 30 April 2022.PMCB Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$70.19 M
+$10.29 M+17.18%
31 July 2024
Summary:
PharmaCyte Biotech quarterly total assets is currently $70.19 million, with the most recent change of +$10.29 million (+17.18%) on 31 July 2024. Over the past year, it has dropped by -$8.68 million (-11.01%). PMCB quarterly total assets is now -23.96% below its all-time high of $92.31 million, reached on 31 October 2021.PMCB Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB Total Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -18.3% | -11.0% |
3 y3 years | +709.0% | -24.0% |
5 y5 years | +936.0% | +1214.9% |
PMCB Total Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -33.9% | +709.0% | -24.0% | +17.2% |
5 y | 5 years | -33.9% | +936.0% | -24.0% | +1215.0% |
alltime | all time | -33.9% | -24.0% |
PharmaCyte Biotech Total Assets History
Date | Annual | Quarterly |
---|---|---|
July 2024 | - | $70.19 M(+17.2%) |
Apr 2024 | $59.90 M(-18.2%) | $59.90 M(-16.1%) |
Jan 2024 | - | $71.36 M(-9.5%) |
Oct 2023 | - | $78.88 M(-1.3%) |
July 2023 | - | $79.88 M(+9.0%) |
Apr 2023 | $73.28 M(-19.1%) | $73.28 M(-6.0%) |
Jan 2023 | - | $77.95 M(-5.3%) |
Oct 2022 | - | $82.35 M(-5.8%) |
July 2022 | - | $87.39 M(-3.6%) |
Apr 2022 | $90.62 M(+1124.0%) | $90.62 M(-1.4%) |
Jan 2022 | - | $91.94 M(-0.4%) |
Oct 2021 | - | $92.31 M(+1290.8%) |
July 2021 | - | $6.64 M(-10.4%) |
Apr 2021 | $7.40 M(+20.1%) | $7.40 M(-10.4%) |
Jan 2021 | - | $8.26 M(-7.6%) |
Oct 2020 | - | $8.94 M(+20.3%) |
July 2020 | - | $7.43 M(+20.5%) |
Apr 2020 | $6.17 M(+6.6%) | $6.17 M(+15.5%) |
Jan 2020 | - | $5.34 M(-0.0%) |
Oct 2019 | - | $5.34 M(-4.8%) |
July 2019 | - | $5.61 M(-3.1%) |
Apr 2019 | $5.78 M(-9.8%) | $5.78 M(-0.9%) |
Jan 2019 | - | $5.84 M(-3.8%) |
Oct 2018 | - | $6.07 M(-14.3%) |
July 2018 | - | $7.08 M(+10.4%) |
Apr 2018 | $6.41 M(-26.0%) | $6.41 M(-4.6%) |
Jan 2018 | - | $6.73 M(-15.0%) |
Oct 2017 | - | $7.92 M(-16.9%) |
July 2017 | - | $9.53 M(+9.9%) |
Apr 2017 | $8.67 M(+21.0%) | $8.67 M(+13.8%) |
Jan 2017 | - | $7.61 M(+13.1%) |
Oct 2016 | - | $6.73 M(-10.5%) |
July 2016 | - | $7.52 M(+5.1%) |
Apr 2016 | $7.16 M(-23.0%) | $7.16 M(-10.5%) |
Jan 2016 | - | $8.00 M(+4.7%) |
Oct 2015 | - | $7.64 M(-6.2%) |
July 2015 | - | $8.14 M(-12.4%) |
Apr 2015 | $9.30 M(-0.2%) | $9.30 M(+40.3%) |
Jan 2015 | - | $6.63 M(-0.5%) |
Oct 2014 | - | $6.66 M(-18.8%) |
July 2014 | - | $8.20 M(-12.0%) |
Apr 2014 | $9.32 M | $9.32 M(+64.5%) |
Jan 2014 | - | $5.66 M(+23.2%) |
Oct 2013 | - | $4.59 M(+35.4%) |
Date | Annual | Quarterly |
---|---|---|
July 2013 | - | $3.39 M(+18.0%) |
Apr 2013 | $2.88 M(+37.8%) | $2.88 M(+17.4%) |
Jan 2013 | - | $2.45 M(+5.8%) |
Oct 2012 | - | $2.32 M(+3.7%) |
July 2012 | - | $2.23 M(+7.0%) |
Apr 2012 | $2.09 M(+68.3%) | $2.09 M(+12.0%) |
Jan 2012 | - | $1.86 M(+8.0%) |
Oct 2011 | - | $1.73 M(+9.5%) |
July 2011 | - | $1.58 M(+27.1%) |
Apr 2011 | $1.24 M(+3.2%) | $1.24 M(+4.1%) |
Jan 2011 | - | $1.19 M(+1.1%) |
Oct 2010 | - | $1.18 M(-0.4%) |
July 2010 | - | $1.18 M(-1.6%) |
Apr 2010 | $1.20 M(-80.1%) | $1.20 M(-73.5%) |
Jan 2010 | - | $4.55 M(-23.5%) |
Oct 2009 | - | $5.94 M(-1.6%) |
July 2009 | - | $6.04 M(+0.0%) |
Apr 2009 | $6.04 M(-20.7%) | $6.04 M(+6.9%) |
Jan 2009 | - | $5.65 M(-11.2%) |
Oct 2008 | - | $6.37 M(-9.0%) |
July 2008 | - | $7.00 M(-8.1%) |
Apr 2008 | $7.62 M(+72.9%) | $7.62 M(+75.4%) |
Jan 2008 | - | $4.34 M(+36.0%) |
Oct 2007 | - | $3.19 M(-19.7%) |
July 2007 | - | $3.98 M(-9.8%) |
Apr 2007 | $4.41 M(-14.2%) | $4.41 M(-9.1%) |
Jan 2007 | - | $4.85 M(+12.5%) |
Oct 2006 | - | $4.31 M(-5.3%) |
July 2006 | - | $4.55 M(-11.5%) |
Apr 2006 | $5.14 M(+1426.7%) | $5.14 M(+1232.2%) |
Jan 2006 | - | $385.50 K(+194.5%) |
Oct 2005 | - | $130.90 K(-15.4%) |
July 2005 | - | $154.80 K(-54.0%) |
Apr 2005 | $336.40 K(+91.5%) | $336.40 K(-63.1%) |
Jan 2005 | - | $912.70 K(-31.1%) |
Oct 2004 | - | $1.32 M(-46.6%) |
July 2004 | - | $2.48 M(+1311.3%) |
Apr 2004 | $175.70 K(>+9900.0%) | $175.70 K(-75.0%) |
Jan 2004 | - | $703.90 K(+8.3%) |
Oct 2003 | - | $650.00 K(>+9900.0%) |
July 2003 | - | $0.00(0.0%) |
Apr 2003 | $0.00(0.0%) | $0.00(0.0%) |
Jan 2003 | - | $0.00 |
Apr 2002 | $0.00 | - |
FAQ
- What is PharmaCyte Biotech annual total assets?
- What is the all time high annual total assets for PharmaCyte Biotech?
- What is PharmaCyte Biotech annual total assets year-on-year change?
- What is PharmaCyte Biotech quarterly total assets?
- What is the all time high quarterly total assets for PharmaCyte Biotech?
- What is PharmaCyte Biotech quarterly total assets year-on-year change?
What is PharmaCyte Biotech annual total assets?
The current annual total assets of PMCB is $59.90 M
What is the all time high annual total assets for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual total assets is $90.62 M
What is PharmaCyte Biotech annual total assets year-on-year change?
Over the past year, PMCB annual total assets has changed by -$13.37 M (-18.25%)
What is PharmaCyte Biotech quarterly total assets?
The current quarterly total assets of PMCB is $70.19 M
What is the all time high quarterly total assets for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly total assets is $92.31 M
What is PharmaCyte Biotech quarterly total assets year-on-year change?
Over the past year, PMCB quarterly total assets has changed by -$8.68 M (-11.01%)